Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,106,928
  • Shares Outstanding, K 46,122
  • Annual Sales, $ 187,340 K
  • Annual Income, $ -9,960 K
  • EBIT $ 4 M
  • EBITDA $ 13 M
  • 60-Month Beta 1.09
  • Price/Sales 5.80
  • Price/Cash Flow N/A
  • Price/Book 9.00

Options Overview Details

View History
  • Implied Volatility 101.36% ( +4.60%)
  • Historical Volatility 68.35%
  • IV Percentile 88%
  • IV Rank 63.83%
  • IV High 130.60% on 08/04/25
  • IV Low 49.75% on 12/11/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 44
  • Volume Avg (30-Day) 162
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 2,991
  • Open Int (30-Day) 2,581

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.02
  • Prior Year 0.01
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.27 +60.74%
on 10/14/25
24.92 -1.50%
on 11/11/25
+8.56 (+53.50%)
since 10/10/25
3-Month
13.64 +79.95%
on 08/25/25
24.92 -1.50%
on 11/11/25
+10.53 (+75.20%)
since 08/11/25
52-Week
9.22 +166.36%
on 06/18/25
24.92 -1.50%
on 11/11/25
+10.57 (+75.70%)
since 11/11/24

Most Recent Stories

More News
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 24.49 (+2.04%)
AxoGen: Q3 Earnings Snapshot

AxoGen: Q3 Earnings Snapshot

AXGN : 24.49 (+2.04%)
Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 24.49 (+2.04%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact...

AXGN : 24.49 (+2.04%)
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 24.49 (+2.04%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact...

AXGN : 24.49 (+2.04%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK , Oct. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact...

AXGN : 24.49 (+2.04%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact...

AXGN : 24.49 (+2.04%)
Canaccord Genuity Keeps Their Buy Rating on AxoGen (AXGN)

Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating on AxoGen today and set a price target of $24.00. The company’s shares closed today at $17.87.Elevate Your Investing Strategy: Take advantage...

AXGN : 24.49 (+2.04%)
Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN

The DJS Law Group announces that it is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or “the Company”) (NASDAQ: AXGN ) for violations of the securities...

AXGN : 24.49 (+2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 25.07
2nd Resistance Point 24.58
1st Resistance Point 24.29
Last Price 24.49
1st Support Level 23.52
2nd Support Level 23.03
3rd Support Level 22.74

See More

52-Week High 24.92
Last Price 24.49
Fibonacci 61.8% 18.92
Fibonacci 50% 17.07
Fibonacci 38.2% 15.21
52-Week Low 9.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar